
Zymeworks
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Market cap
$868m
Enterprise value
$621m
Share price
$12.55 ZYME
Authorizing premium user...
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics.